#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14676	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2134	683.9	0	.	n	.	0	C451T	SNP	451	451	C	739	739	T	875	T	811	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14676	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2134	683.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1472	1472	C	852	C	792	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27058	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3520	765.9	0	.	n	.	0	T695C	SNP	695	695	T	1025	1025	C	846	C	785	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27058	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3520	765.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2301	2301	C	914	C	835	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27058	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3520	765.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2375	2375	A	847	A	791	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27058	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3520	765.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2927	2927	C	835	C	790	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1862	folP	855	855	100.0	folP.l6.c4.ctg.1	1500	123.3	1	SNP	p	R229S	1	.	.	685	687	AGC	976	978	AGC	197;201;202	A;G;C	180;185;183	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5684	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3282	171.9	1	SNP	p	S91F	1	.	.	271	273	TTC	458	460	TTC	176;174;174	T;T,C;C,T	166;164,1;161,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5684	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3282	171.9	1	SNP	p	G95N	0	.	.	283	285	GGC	470	472	GGC	179;178;176	G;G;C	166;162;166	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5684	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3282	171.9	1	SNP	p	D95G	1	.	.	283	285	GGC	470	472	GGC	179;178;176	G;G;C	166;162;166	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1526	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1334	113.9	1	SNP	p	G45D	0	.	.	133	135	GGC	464	466	GGC	187;184;183	G;G;C	171;167;171	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	796	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	891	88.5	0	.	n	.	0	A197.	DEL	197	197	A	546	546	A	179	A	166	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5648	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2925	192.4	1	SNP	p	D86N	0	.	.	256	258	GAC	588	590	GAC	227;227;235	G;A;C,T	204;198;209,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5648	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2925	192.4	1	SNP	p	S87R	1	.	.	259	261	CGT	591	593	CGT	233;233;227	C,T;G;T	211,1;212;205	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5648	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2925	192.4	1	SNP	p	R87W	0	.	.	259	261	CGT	591	593	CGT	233;233;227	C,T;G;T	211,1;212;205	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5648	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2925	192.4	1	SNP	p	R87I	0	.	.	259	261	CGT	591	593	CGT	233;233;227	C,T;G;T	211,1;212;205	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5648	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2925	192.4	1	SNP	p	S88P	0	.	.	262	264	TCC	594	596	TCC	229;229;228	T;C;C	207;208;211	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4074	parE	1986	1986	99.95	parE.l15.c17.ctg.1	2615	154.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1563	1565	GGC	217;215;213	G;G;C	199;197;193	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	167.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1228	1230	GCC	209;206;208	G;C;C	193;192;193	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	167.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1231	1233	ATG	212;214;212	A;T;G	198;198;196	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	167.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1243	1245	ACC	212;210;207	A;C;C	190;188;188	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	167.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1243	1245	ACC	212;210;207	A;C;C	190;188;188	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	167.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1744	1746	ACC	239;238;239	A;C;C	219;224;222	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	167.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1798	1800	GCG	232;232;231	G;C;G	218;216;217	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	167.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1798	1800	GCG	232;232;231	G;C;G	218;216;217	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	167.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1921	1923	GGT	185;184;183	G;G;T	165;165;164	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	167.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1930	1932	AGC	177;175;174	A,G;G;C,G	154,1;152;152,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	167.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1948	1950	CCG	164;166;163	C,G;C,G;G,C	120,8;124,4;121,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5770	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3034	189.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1582	1584	CCG	204;204;202	C;C;G	183;188;178	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2184	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1941	112.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	701	701	C	178	C	165	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2882	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1518	188.0	1	SNP	p	G120K	1	.	.	358	360	AAG	620	622	AAG	251;253;253	A;A;G,T	229;234;231,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2882	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1518	188.0	1	SNP	p	A121N	1	.	.	361	363	AAC	623	625	AAC	255;257;257	A;A;C	235;238;235	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2882	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1518	188.0	1	SNP	p	N121D	0	.	.	361	363	AAC	623	625	AAC	255;257;257	A;A;C	235;238;235	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10990	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4827	227.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1152	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1150	99.7	1	SNP	p	V57M	1	.	.	169	171	ATG	567	569	ATG	252;253;253	A;T;G	237;234;233	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
